Search results

Selected filters:

Europe
Litigation

Article type

Topic

Sector

Jurisdictions

496 results found for your search

Sort options
19 November 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

16 November 2019

Patents are politics, as an eagerly awaited UK Supreme Court FRAND licensing ruling may soon show

A judgment that upholds the Unwired Planet and Conversant decisions could well leave British Prime Minister Boris Johnson in a difficult position

15 November 2019

Another big LG assertion could signal a strategy shift

The Korean electronics giant has accused TCL of infringement in Germany, in another lawsuit targeting a Chinese rival

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

11 November 2019

It is time for the German courts to be courageous on FRAND

The Dusseldorf Court of Appeal’s decision in Unwired Planet v Huawei is one that had licensees cheering and licensors in despair - but it may not last long 

09 November 2019

The patent dodgers trolling the IP landscape

IPCom is one of Europe’s oldest NPEs – and usually one of its most reticent. Not anymore, though. In this opinion piece, managing director Pio Suh explains why he believes firms such as his have a key role to play in FRAND licensing

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019

05 November 2019

Monsanto prevails in key $7.7 billion Brazilian licensing lawsuit

In a big win for patent owners, the first-of-its-kind ruling upholds biotech innovators’ rights to collect royalties on saved GM seeds

02 November 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators

01 November 2019

<em>Unwired Planet</em> and <em>Conversant</em> decisions likely to stand, which leaves Huawei and ZTE with big calls to make

The justices hearing the much-watched UK Supreme Court FRAND licensing appeals did not seem disposed to reverse, but that may not be the end of the story

25 October 2019

GlobalFoundries’ patent attack on TSMC may have come too late  

In-depth analysis shows that the Taiwanese semiconductor business has not only bulked up its portfolio over the last decade, but also considerably improved its quality

25 October 2019

Intel faces multi-pronged injunction threat in China, antitrust suit reveals

Fortress-owned vehicle monetising NXP rights has brought multiple Chinese suits as part of its pressure campaign on the US chipmaker

25 October 2019

UK Supreme Court hands employee-inventor a dramatic £2 million victory

Judgment vindicates professor’s 20-year fight for share of Unilever licensing profit and looks set to reshape British law on employee compensation for inventions

24 October 2019

Exclusive: Inside the IP protection strategy of an innovative generic

Centrient’s head of IP lifts the lid on why the company has been putting more focus on IP enforcement in India and explains the attractions of trade secrets